Seeing Is Believing
Currently out of the existing stock ratings of Ryan Zimmerman, 207 are a BUY (90%), 21 are a HOLD (9.13%), 2 are a SELL (0.87%).
Analyst Ryan Zimmerman, currently employed at BTIG, carries an average stock price target met ratio of 60.04% that have a potential upside of 34.21% achieved within 226 days.
Ryan Zimmerman’s has documented 429 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ORGO, Organogenesis Holdings at 26-Sep-2025.
Analyst best performing recommendations are on ORGO (ORGANOGENESIS HOLDINGS).
The best stock recommendation documented was for STAA (STAAR SURGICAL COMPANY) at 12/28/2022. The price target of $67 was fulfilled within 14 days with a profit of $20.18 (43.1%) receiving and performance score of 30.79.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$85
$7.62 (9.85%)
$100
7 days ago
(28-Sep-2025)
4/5 (80%)
$10.89 (14.69%)
119
Hold
$77.53
$0.15 (0.19%)
$85.88
1 months 15 days ago
(20-Aug-2025)
2/2 (100%)
$-1.65 (-2.08%)
111
Buy
$110
$32.62 (42.16%)
$120
1 months 15 days ago
(20-Aug-2025)
8/11 (72.73%)
$30.82 (38.92%)
338
Buy
$95
$17.62 (22.77%)
$108
1 months 15 days ago
(20-Aug-2025)
7/11 (63.64%)
$15.82 (19.98%)
285
Buy
$107
$29.62 (38.28%)
$107
1 months 16 days ago
(19-Aug-2025)
15/27 (55.56%)
$25.96 (32.03%)
396
Which stock is Ryan Zimmerman is most bullish on?
Which stock is Ryan Zimmerman is most reserved on?
What Year was the first public recommendation made by Ryan Zimmerman?